The Expression of Protooncogenes in Skeletal Muscle

  • Jeffrey D. Turner
  • Jan Novakofski
  • Peter J. Bechtel


Oncogenes are DNA sequences that when expressed lead to rapid cellular proliferation characteristic of malignant transformation. The nontransforming normal cellular cognates of the oncogenes are protooncogenes. These sequences are highly conserved and are thought to be involved in the process of normal cell replication (Bishop, 1983).


Tyrosine Kinase Activity PDGF Receptor Oncogene Expression Mouse Skeletal Muscle Chicken Muscle 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Birnstiel, M. L., M. Busslinger and K. Strub. 1985. Transcription termination and 3’ processing: the end is in site! Cell 41:349.PubMedCrossRefGoogle Scholar
  2. Bishop, J. M. 1983. Cellular oncogenes and retroviruses. Annu. Rev. Biochem. 52:301.PubMedCrossRefGoogle Scholar
  3. Capatanaki, Y. G., J. Ngai, C. N. Flytzanis and E. Lazarides. 1983. Tissue-specific expression of two mRNA species transcribed from a single vimentin gene. Cell 35:411.CrossRefGoogle Scholar
  4. Coffin, J. M., H. E. Varmus, J. M. Bishop, M. Essex, W. D. Hardy Jr, G. S. Martin, N. E. Rosenberg, E. M. Scolnick, R. A. Weinberg and P. K. Vogtt. 1981. Proposal for naming host cell-derived inserts in retrovirus genomes. J. Virol. 40:953.PubMedGoogle Scholar
  5. Colby, W. W., E. Y. Chen, D. H. Smith and A. D. Levinson. 1983. Identification and nucleotide sequence of a human locus homologous to the v-myc oncogene of avian myelocytomatosis virus MC 29. Nature 301:722.PubMedCrossRefGoogle Scholar
  6. Coll, J., S. Saule, P. Martin, M. B. Raes, C. Lagrou, T. Graf, H. Beug, I. E. Simon and D. Stehelin. 1983. The cellular oncogenes c-myc, c-myb and c-erb are transcribed in defined types of avian hematopoietic cells. Exp. Cell Res. 149:151.PubMedCrossRefGoogle Scholar
  7. Devare, S. G., E. P. Reddy, J. D. Law, K. C. Robbins and S. A. Aaronson. 1983. Nucleotide sequence of the simian sarcoma virus genome: demonstration that its acquired cellular se- quences encode the transforming gene product p28sis. Proc. Natl. Acad. Sci. USA 80:731.PubMedCrossRefGoogle Scholar
  8. Donner, P., I. Greiser-Wilke and K. Moelling. 1982. Nuclear localization and DNA binding of the transforming gene product of avian myelocytomatosis virus. Nature 296:262.PubMedCrossRefGoogle Scholar
  9. Endo, T. and B. Nadal-Ginard. 1986. Transcriptional and post-transcriptional control of c-myc during myogenesis: its mRNA remains induced in differentiated cells and does not suppress the differentiated phenotype. Mol. Cell. Biol. 6:1412.PubMedGoogle Scholar
  10. Fujita, J., S. K. Srivastava, M. H. Kraus, J. S. Rhim, S. R. Tronick and S. H. Aaronson. 1985. Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tu- mors. Proc. Natl. Acad. Sci. USA 82:3849.PubMedCrossRefGoogle Scholar
  11. Garrett, J. S., S. R. Coughlin, H. L. Niman, P. M. Tremble, G. M. Giels and L. T. Williams. 1984. Blockade of autocrine stimulation in simian sarcoma virus-transformed cells reverses down-regulation of platelet-derived growth factor receptors. Proc. Natl. Acad. Sci. USA 81:7466.PubMedCrossRefGoogle Scholar
  12. Gibbs, J. B., I. S. Signal, M. Poe and E. M. Scolnick. 1984. Intrinsic GTPase activity distin- guishes normal and oncogenic ras p21 molecules. Proc. Natl. Acad. Sci. USA 81:5704.PubMedCrossRefGoogle Scholar
  13. Gilman, A. G. 1984. G proteins and dual control of adenylate cyclase. Cell 36:577.PubMedCrossRefGoogle Scholar
  14. Gonda, T. J., D. K. Sheiness and J. M. Bishop. 1982. Transcripts from the cellular homologs of retroviral oncogenes: distributions among chicken tissues. Mol. Cell. Biol. 2:617.PubMedGoogle Scholar
  15. Guerrero, I., A. Villasante, V. Corces and A. Pellicer. 1985. Loss of the normal N-ras allele in a mouse thymic lymphoma induced by a chemical carcinogen. Proc. Natl. Acad. Sci. USA 82:7810.PubMedCrossRefGoogle Scholar
  16. Hann, S. R., H. D. Abrams, L. R. Rohrschneider and R. N. Eisenman. 1983. Proteins encoded by v-myc and c-myc oncogenes: identification and localization in acute leukemia virus trans- formants and bursal lymphoma cell lines. Cell 34:789.PubMedCrossRefGoogle Scholar
  17. Hannik, M. and D. J. Donoghue. 1984. Requirement for a signal sequence in biological expression of the v-sis oncogene. Science 226:1197.CrossRefGoogle Scholar
  18. Helfman, D. M., S. Cheley, E. Kuissmanen, L. A. Finn and Y. Yamawaki-Katoake. 1986. Non- muscle and muscle tropomyosin isoforms are expressed from a single gene by alternate RNA splicing and polyadenylation. Mol. Cell. Biol. 6:3582.PubMedGoogle Scholar
  19. Hunter, T. 1982. Synthetic peptide substrates for a tyrosine protein kinase. J. Biol. Chem. 257:4843.PubMedGoogle Scholar
  20. Johnsson, A., C. Betsholtz, C. H. Heldin and B. Westermark. 1985. Antibodies against platelet- derived growth factor inhibit acute transformation by simian sarcoma virus. Nature 317:438.PubMedCrossRefGoogle Scholar
  21. Johnsson, A., C. Betsholtz, C. H. Heldin and B. Westermark. 1986. The phenotype characteristics of simian sarcoma virus-transformed human fibroblasts suggest that the v-sis gene product acts solely as a PDGF receptor agonist in cell transformation. EMBO J. 5:1535.PubMedGoogle Scholar
  22. Kasuga, M., Y. Fugita-Yamaguchi, D. L. Blithe and C. R. Kahn. 1983. Tyrosine-specific protein kinase activity is associated with the purified insulin receptor. Proc. Natl. Acad. Sci. USA 80:2137.PubMedCrossRefGoogle Scholar
  23. Kelly, K., B. H. Cochran, C. D. Stiles and P. Leder. 1983. Cell specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35:603.PubMedCrossRefGoogle Scholar
  24. King, C. R., N. A. Giese, K. C. Robbins and S. A. Aaronson. 1985. In virto mutagenesis of the v-sis transforming gene defines functional domains of its growth factor-related product. Proc. Natl. Acad. Sci. USA 82:5295.PubMedCrossRefGoogle Scholar
  25. Kohl, N. E., N. Kanda, R. R. Schreck, G. Bruns, S. A. Latt, F. Gilbert and F. W. Alt. 1983. Transposition and amplification of oncogene-related sequences in human neuroblastomas. Cell 35:359.PubMedCrossRefGoogle Scholar
  26. Leon, J., I. Guerrero and A. Pellicer. 1987. Differential expression of the ras gene family in mice. Mol. Cell. Biol 7:1535.PubMedGoogle Scholar
  27. Letterio, J. J., S. R. Coughlin and L. T. Williams. 1986. Pertussis toxin-sensitive pathway in the stimulation of c-myc expression and DNA synthesis by bombesin. Science 234:117.CrossRefGoogle Scholar
  28. Li, Y., C. A. Holland, J. W. Hartley and N. Hopkins. 1984. Viral integration near c-myc in 10 – 20% of MCF 247-induced AKR lymphomas. Proc. Natl. Acad. Sci. USA 81:6808.PubMedCrossRefGoogle Scholar
  29. Neel, B. G., W. S. Hayward, H. L. Robinson, J. Fang and S. M. Astrin. 1981. Avian leukosis virus-induced tumors have common proviral integration sites and synthesize discrete new RNAs: oncogenesis by promoter insertion. Cell 23:323.PubMedCrossRefGoogle Scholar
  30. Ong, J., S. Yamashita and S. Melmed. 1987. Insulin-like growth factor 1 induces c-foc messenger ribonucleic acid in L6 rat skeletal muscle cells. Endocrinology 120:353.PubMedCrossRefGoogle Scholar
  31. Pelicci, P. G., D. M. Knowles, I. Magrath and R. Dalla-Favera. 1986. Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. Proc. Natl. Acad. Sci. USA 83:2984.PubMedCrossRefGoogle Scholar
  32. Pike, L. J., D. F. Bowen-Pope, R. Ross and E. G. Krebs. 1983. Characterization of platelet- derived growth factor-stimulated phosphorylation in cell membranes. J. Biol. Chem. 258:9383.PubMedGoogle Scholar
  33. Pike, L. J., B. Gallis, J. E. Casnellie, P. Bornstein and E. G. Krebs. 1982. Epidermal growthfactor stimulates the phosphorylation of synthetic tyrosine-containing peptides by A431 cell membranes. Proc. Natl. Acad. Sci. USA 79:1443.PubMedCrossRefGoogle Scholar
  34. Robbins, K. C, H. N. Antoniades, S. G. Devare, M. W. Hunkapiller and S. A. Aaronson. 1983. Structural and immunological similarities between simian sarcoma virus gene product(s) and human platelet-derived growth factor. Nature 305:605.PubMedCrossRefGoogle Scholar
  35. Sefton, B. M., I. S. Trowbridge, J. S. Cooper and E. M. Scolnick. 1982. The transforming proteins of Rous sarcoma virus. Harvy sarcoma virus and Abelson virus contain tightly bound lipid. Cell 31:465.PubMedCrossRefGoogle Scholar
  36. Sejersen, T., J. Sumegi and N. R. Ringertz. 1985a. Density-dependent arrest of DNA replication is accompanied by decreased level of c-myc mRNA in myogenic but not in differentiation- defective myoblasts. J. Cell. Physiol. 125:465.PubMedCrossRefGoogle Scholar
  37. Sejersen, T., J. P. Wahrmann, J. Sumegi and N. R. Ringertz. 1985b. Change in expression of oncogenes (sis, ras, myc, abl) during in vitro differentiation of L6 rat myoblasts. In: B. Wahren, G. Holm, S. Hammarstrom and P. Perlmann (Eds.) Molecular Biology of Tumor Cells, pp 243–250. Raven Press, New York.Google Scholar
  38. Shibuya, M., H. Hanafusa and P. C. Balduzzi. 1982. Cellular sequences related to three new oncogenes of avian sarcoma virus (fps, yes and ros) and their expression, in normal and transformed cells. J. Virol. 42:143.PubMedGoogle Scholar
  39. Starksen, N. F., P. C. Simpson, N. Bishopric, S. R. Coughlin, W. M. F. Lee, J. A. Escobedo and L. T. Williams. 1986. Cardiac myocyte hypertrophy is associated with c-myc protoon-cogene expression. Proc. Natl. Acad. Sci. USA 83:8348.PubMedCrossRefGoogle Scholar
  40. Steffen, D. 1984. Proviruses are adjacent to c-myc in some murine leukemia virus-induced lym- phomas. Proc. Natl. Acad. Sci. USA 81:2097.PubMedCrossRefGoogle Scholar
  41. Stroobant, P. and M. D. Waterfield. 1984. Purification and properties of porcine platelet-derived growth factor. EMBO J. 3:2963.PubMedGoogle Scholar
  42. Sweet, R. W., S. Yokoyama, T. Kamata, J. R. Feramisco, M. Rosenberg and M. Gross. 1984. The product of ras is a GTPase and the T24 oncogene mutant is deficient in the activity. Nature 311:273.PubMedCrossRefGoogle Scholar
  43. Tanabe, T., T. Nukada, Y. Nishikawa, K. Sugimoto, H. Suzuki, H. Takahashi, M. Noda, T. Haga, A. Ichiyama, K. Kangawa, N. Minamino, H. Matsuo, and S. Numa. 1985. Primary structure of the α-subunit of transducin and its relationship to ras proteins. Nature 315:242.PubMedCrossRefGoogle Scholar
  44. Turner, J. D. 1987. Molecular mechanisms of growth hormone induced muscle hypertrophy. Ph.D. Thesis. Univ. of Illinois, Urbana.Google Scholar
  45. Turner, J. D., P. J. Bechtel and J. E. Novakofski. 1986. Interaction between age and GH3 tumor implantation in Wistar-Furth rats. Growth 50:402.PubMedGoogle Scholar
  46. Wang, J. Y. and L. T. Williams. 1984. A v-sis oncogene protein produced in bacteria competes for platelet-derived growth factor binding to its receptor. J. Biol. Chem. 259:10645.PubMedGoogle Scholar
  47. Watt, R. A., A. R. Shatzman and M. Rosenberg. 1985. Expression and characterization of the human c-myc DNA-binding protein. Mol. Cell. Biol. 5:448.Google Scholar
  48. Watt, R., L. W. Stanton, K. B. Marcu, R. C. Gallo, C. M. Croce and G. Rovera. 1983. Nucleo- tide sequence of cloned cDNA of human c-myc oncogene. Nature 303:725.PubMedCrossRefGoogle Scholar
  49. Witte, O. N., N. Rosenberg and D. Baltimore. 1979. Preparation of syngenic tumor regressor serum reactive with the unique determinants of the Abelson murine leukemia virus-encoded P120 protein at the cell surface. J. Virol. 31:776.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • Jeffrey D. Turner
    • 1
  • Jan Novakofski
    • 2
  • Peter J. Bechtel
    • 2
  1. 1.Department of Animal ScienceMacDonald College of McGill UniversityCanada
  2. 2.Muscle Biology LaboratoryUniversity of IllinoisUrbanaUSA

Personalised recommendations